美国私人保险分娩者椎管内分娩镇痛使用率、硬脊膜穿破后头痛发生率及硬膜外血补片放置情况(2008-2015)
基于Truven MarketScan商业保险索赔数据库分析1,752,243例分娩,阴道分娩占64.6%,其中72.9%接受椎管内分娩镇痛,硬脊膜穿破后头痛(PDPH)发生率为0.58%(95%CI 0.57-0.60)。以阴道分娩接受椎管内镇痛为参照,未先接受椎管内镇痛的行剖宫产者PDPH风险比为1.1(95%CI 1.05-1.15;PDPH后硬膜外血补片放置率在阴道分娩接受椎管内镇痛者为68.4%,剖宫产先接受椎管内镇痛者为67.2%,剖宫产未先接受椎管内镇痛者为59.7%;首次血补片距分娩中位天数3天,8.3%接受第二次,0.1%接受第三次。
要点
- 阴道分娩中72.9%接受椎管内分娩镇痛,PDPH发生率为0.58%。
- 未先接受椎管内镇痛的行剖宫产者PDPH风险高于阴道分娩接受椎管内镇痛者。
- PDPH后硬膜外血补片放置率约60%-68%,重复血补片罕见。
核心结论
- 本研究证实了既往关于椎管内分娩镇痛使用率和PDPH发生率的报道。
- 与阴道分娩接受椎管内镇痛相比,未先接受椎管内镇痛的行剖宫产者PDPH发生率更高,推测与有意硬脊膜穿破有关。
- 先接受椎管内镇痛的行剖宫产者PDPH发生率更低,可能与第二产程避免屏气用力有关。
- 硬膜外血补片是治疗PDPH的常用策略,在有椎管内镇痛史者中更常用,重复血补片罕见。
研究设计与样本
- 基于Truven MarketScan商业保险索赔与 encounters 数据库的回顾性队列分析,纳入1,752,243例分娩。
- 通过Current Procedural Terminology(CPT)编码识别分娩方式、镇痛和/或手术麻醉信息及硬膜外血补片放置。
- 通过International Classification of Diseases, Ninth Revision(ICD-9)编码识别PDPH。
主要发现
- 阴道分娩占样本64.6%,其中72.9%接受椎管内分娩镇痛,PDPH发生率为0.58%(95%CI 0.57-0.60)。
- 硬膜外血补片放置率:阴道分娩接受椎管内镇痛后PDPH者为68.4%,剖宫产先接受椎管内镇痛后PDPH者为67.2%,剖宫产未先接受椎管内镇痛后PDPH者为59.7%。
- 首次血补片距分娩中位天数3天;8.3%接受第二次血补片,0.1%接受第三次;接受重复血补片者首次血补片距分娩中位间隔1天。
关键数值与推荐
- 阴道分娩接受椎管内镇痛者PDPH发生率为0.58%(95%CI 0.57-0.60)。
- PDPH后硬膜外血补片放置率分别为68.4%、67.2%、59.7%(对应上述三组)。
- 首次血补片距分娩中位天数3天;重复血补片率8.3%(第二次)和0.1%(第三次)。
临床怎么用
- 商业保险数据可用于评估椎管内分娩镇痛使用率及PDPH、硬膜外血补片的发生情况。
- 剖宫产未先接受椎管内镇痛者PDPH风险较高,应加强产后头痛监测。
- 硬膜外血补片是PDPH常用治疗手段,多数在分娩后3天内实施,重复血补片少见。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neuraxial analgesia is the gold standard for labor analgesia in the United States, and postdural puncture headache (PDPH) is one of the most common complications. PDPH is frequently treated with an epidural blood patch (EBP), but conservative treatment approaches remain common. Our current understanding of the incidence of PDPH and the frequency of EBP utilization is heavily based on reports from academic medical centers. We studied a private insurance database to provide estimates of neuraxial labor analgesia (NLA) use and PDPH and EBP incidence in the United States. METHODS: Labor and delivery insurance claims from the Truven MarketScan Commercial Claims and Encounters database were analyzed. Mode of delivery, analgesic and/or operative anesthesia information, and EBP placement were identified using Current Procedural Terminology (CPT) codes. PDPH was identified using International Classification of Diseases, Ninth Revision (ICD-9) codes. RESULTS: The analytic dataset consisted of 1,752,243 deliveries. Vaginal deliveries (VD) comprised 64.6% of the sample. Of these, 72.9% received NLA, with a PDPH incidence of 0.58% (95% confidence interval [CI], 0.57-0.60). Using VD with NLA as a referent, the risk ratio for PDPH following cesarean delivery (CD) without a prior NLA was 1.1 (95 CI, 1.05-1.15; P = .0001), while the risk ratio for PDPH following CD with a prior NLA was 0.81 (95% CI, 0.76-0.87; P < .0001). EBP placement was documented in 68.4% PDPH cases following VD with NLA, 67.2% of PDPH cases following CD with prior NLA, and 59.7% of PDPH cases following CD without prior NLA. The median number of days between delivery and first and EBP was 3. A second EBP was performed in 8.3% of initially patched patients, and a third in 0.1%. In patients who went on to receive a repeat EBP, the median interval between delivery and the first EBP was 1 day. CONCLUSIONS: This analysis confirms findings of prior studies regarding the present utilization of neuraxial analgesia and the incidence of PDPH. When compared to patients undergoing VD with NLA, patients having CD without NLA had a higher incidence of PDPH, presumably due to intentional dural puncture. Women having CD with a prior NLA had a lower incidence of PDPH, possibly due to avoidance of pushing during the second stage of labor. EBP was a commonly pursued strategy for the treatment of PDPH and was more commonly pursued in patients with a history of NLA. Repeat EBP was rare.
引用
- Delgado C, Bollag L, Van Cleve W, et al. Neuraxial Labor Analgesia Utilization, Incidence of Postdural Puncture Headache, and Epidural Blood Patch Placement for Privately Insured Parturients in the United States (2008-2015). Anesth Analg. 2020. PMID: 31804407. doi:10.1213/ANE.0000000000004561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。